Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Biolog-id logo — The smart healthcare solution for the management and traceab...

Biolog-id

The smart healthcare solution for the management and traceability of sensitive health products.

Founded 2005 France France 68 employees Venture round Total: $62.00M Analytics, Biotechnology +1

General Information

Company Name Biolog-id
Founded Year 2005
Location France France
Employees 68
Industries Analytics, Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Biolog-id. To contact Biolog-id, visit biolog-id.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biolog-id compare?

A PDF of Biolog-id and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biolog-id soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biolog-id

Biolog-id is a pioneering healthcare solution that addresses the challenging task of managing and tracing sensitive health products. With the rise in blood donations and cancer cases worldwide, the demand for blood and chemotherapy products continues to escalate, making it crucial to ensure a constant supply of high-quality products. Leveraging IoT, Biolog-id offers real-time access to product and patient information, enabling healthcare professionals to focus on enhancing patient safety, reducing operational costs, and improving working conditions. Established in 2005 and based in France, the company specializes in Analytics, Biotechnology, and Health Care. The latest funding round saw a significant $25.00M investment from Xerys Capital on 05 May 2022. Their innovative solution, Biolog-connect®, utilizes Radio Frequency Identification technology to manage and trace sensitive health products, including transfusion, plasma, and chemotherapy supply chains. For more information, visit their official website: [Biolog-id](https://www.biolog-id.com/contact-us/).

Business keywords: IoT solutions, RFID technology, medical supply chain management, patient safety enhancement, blood transfusion management, plasma supply chain management, chemotherapy supply chain management, traceability solutions, electronic identification solutions, life science solutions, medical data processing, healthcare logistics, healthcare hardware development, healthcare software development

Services & Products

Transforming routine processes for sensitive therapeutic products into actionable data
Improved blood products chain management
Full traceability for plasma used in medicinal products compounding
Optimizing injectable therapies workflow and maintaining their safety and security
Data analysis application for obtaining comprehensive graphical dashboards and reports

Target Customers

Healthcare professionals Hospitals and clinics Blood banks Pharmaceutical companies Medical supply chain managers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Biolog $25.00M 1
Xerys Captial
Xerys Captial
05 May 2022
Venture Round Biolog €30.00M 1
Xerys Captial
Xerys Captial
19 Nov 2019
Venture Round Biolog €7.00M 1
Xerys Captial
Xerys Captial
08 Nov 2016

Biolog-id Alternatives & Competitors

View All Alternatives
Biolog-id vs
Wavemark Technologies Inc
Wavemark Technologies Inc United States

The future of clinical supply chain optimization

Debt Financing
2 employees
Analytics, Health Care
Compare Biolog-id vs Wavemark Technologies Inc
Biolog-id vs
HemaSource, Inc
HemaSource, Inc United States

Helping providers manage the business of care.

Venture round
102 employees
Biotechnology, Health Care
Compare Biolog-id vs HemaSource, Inc
Biolog-id vs
Walkky
Walkky United States

AI Platform for Cardiovascular Diagnosis

Non Equity Assistance
7 employees
Analytics, Health Care
View all alternatives

FAQ About Biolog-id

The smart healthcare solution for the management and traceability of sensitive health products.
Biolog-id was founded in 2005.
Biolog-id is headquartered in France.
Biolog-id operates in Analytics, Biotechnology and Health Care. Its work centres on IoT solutions, RFID technology, medical supply chain management and patient safety enhancement. Its customers include Healthcare professionals, Hospitals and clinics and Blood banks.
Biolog-id has approximately 68 employees.
Biolog-id has completed 3 funding rounds, raising a total of $62.00M. The latest funding stage is Venture round.
Biolog-id offers: Transforming routine processes for sensitive therapeutic products into actionable data, Improved blood products chain management, Full traceability for plasma used in medicinal products compounding, Optimizing injectable therapies workflow and maintaining their safety and security, Data analysis application for obtaining comprehensive graphical dashboards and reports.
Top alternatives and competitors to Biolog-id include Wavemark Technologies Inc, HemaSource, Inc, Walkky, ProVen Pharma, LifeSemantics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biolog-id and Wavemark Technologies Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biolog-id, https://bouncewatch.com/company/biolog-id, updated 16 February 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout